Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 29, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.6K

In Vivo Study on Doxycycline Protective Mechanisms during Myocardial Ischemia Injury in Rats.

Anna Krzywonos-Zawadzka1, Agnieszka Olejnik1, Grzegorz Sawicki1,2

  • 1Division of Clinical Chemistry and Laboratory Hematology, Department of Medical Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.

Biomedicines
|March 28, 2024
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The influence of platelets and platelet-derived extracellular vesicles on the injury of cardiomyocytes under static hypoxia/reoxygenation conditions.

Scientific reports·2026
Same author

siRNA-mediated inhibition of NTT-MMP-2 reduces oxidative stress and apoptotic signaling in an ex vivo model of ischemia/reperfusion injury.

Scientific reports·2025
Same author

Klotho protein alleviates heart ischemia/reperfusion injury and oxidative stress through regulation of the NOS/MMP pathway.

Scientific reports·2025
Same author

Diagnostic potential of increased Klotho and FGF23 protein concentrations after myocardial infarction in patients with acute coronary syndrome.

Cardiology journal·2025
Same author

Use of FGF-23 and sαKlotho for Risk Stratification in Patients with Acute Heart Failure.

Journal of clinical medicine·2025
Same author

AI Algorithms for Modeling the Risk, Progression, and Treatment of Sepsis, Including Early-Onset Sepsis-A Systematic Review.

Journal of clinical medicine·2024

Doxycycline protects the heart from myocardial ischemia/reperfusion (I/R) injury by inhibiting matrix metalloproteinases (MMPs). This study shows doxycycline reduces protein degradation and improves heart function after I/R events.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pharmacology

Background:

  • Myocardial ischemia/reperfusion (I/R) injury involves degradation of myosin light chain 1 (MLC1) and troponin I (TnI) by matrix metalloproteinases (MMPs).
  • Oxidative stress exacerbates I/R injury by increasing myosin light chain kinase and nitric oxide synthase activity, leading to protein modifications and degradation.

Purpose of the Study:

  • To investigate the protective effects of doxycycline against myocardial I/R injury in a rat model.
  • To evaluate the impact of doxycycline on MMP activity and cardiac biomarkers.

Main Methods:

  • Wistar rats underwent left anterior descending coronary artery occlusion to induce I/R injury.
  • Doxycycline was administered intraperitoneally before occlusion.
  • Transthoracic echocardiography, biochemical tests (TnI, LDH, MLC1, MMP-2, MMP-9), gelatinase activity, and cytotoxicity were assessed.
Keywords:
LADMLC1MMPsdoxycyclineischemic heart diseaserat myocardial infraction

More Related Videos

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

5.9K
Acute Myocardial Infarction in Rats
07:45

Acute Myocardial Infarction in Rats

Published on: February 16, 2011

53.1K

Related Experiment Videos

Last Updated: Jun 29, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.6K
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

5.9K
Acute Myocardial Infarction in Rats
07:45

Acute Myocardial Infarction in Rats

Published on: February 16, 2011

53.1K

Main Results:

  • Doxycycline administration increased cardiac TnI and LDH content and decreased cytotoxicity.
  • A reduction in MMP-2 and MMP-9 concentrations and MMP-2 activity was observed.
  • Echocardiographic parameters showed improvement 7 days after surgery.

Conclusions:

  • Inhibition of MMPs by doxycycline in vivo demonstrates a protective effect against myocardial I/R injury.
  • Doxycycline shows potential as a therapeutic agent for managing I/R injury.